| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Acts as a DNA methyltransferase inhibitor; can disrupt transcriptional activities, affecting the coactivation functions of PNRC1. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that may indirectly affect PNRC1 by altering chromatin structure and nuclear receptor binding. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor that could affect nuclear receptor interactions with PNRC1. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Inhibits SP1 binding to GC-rich DNA; can affect transcriptional regulation, thereby influencing PNRC1 activity. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Hsp90 inhibitor that could disrupt PNRC1's interaction with other proteins in the nucleus. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Rho kinase (ROCK) inhibitor that may affect nuclear-cytoplasmic shuttling of PNRC1. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Affects BRD4 bromodomains, potentially interfering with PNRC1 mediated transcription. | ||||||
GSK 525762A | 1260907-17-2 | sc-490339 sc-490339A sc-490339B sc-490339C sc-490339D | 5 mg 10 mg 50 mg 100 mg 1 g | $300.00 $540.00 $940.00 $1680.00 $5900.00 | ||
Another BRD4 inhibitor; alters chromatin state and may influence PNRC1 interaction with nuclear receptors. | ||||||
A-485 | 1889279-16-6 | sc-507493 | 5 mg | $275.00 | ||
Inhibits p300/CBP, which are general transcription coactivators that may act in concert with PNRC1. | ||||||
GSK 650394 | 890842-28-1 | sc-361201 sc-361201A | 10 mg 50 mg | $187.00 $769.00 | 8 | |
Serum- and glucocorticoid-induced kinase 1 (SGK1) inhibitor; could influence PNRC1 indirectly through cortisol signaling. | ||||||